Preserved Visual Acuity in Anterior Ischemic Optic Neuropathy Secondary to Giant Cell (temporal) Arteritis
https://doi.org/10.5281/zenodo.10371776
PDF

How to Cite

Aileen A. Antonio-Santos, Sally J. Murad-Kejbou, Rod Foroozan, Sunita Yedavally, David I. Kaufman, & Eric R. Eggenberger. (2023). Preserved Visual Acuity in Anterior Ischemic Optic Neuropathy Secondary to Giant Cell (temporal) Arteritis. Journal of Vascular and Interventional Neurology, 8(5). Retrieved from https://ojs.jvin.org/index.php/jvin/article/view/262

Abstract

Objective—To evaluate the prevalence and clinical profile of patients with biopsy-proven arteritic anterior
ischemic optic neuropathy presenting with preserved visual acuity of 20/40 or better and those with an initial poor visual acuity of 20/50 or worse through a retrospective chart review
Results—Nine of 37 patients with arteritic anterior ischemic optic neuropathy presented with a preserved
visual acuity of 20/40 or better in the affected eye. All patients with preserved visual acuity had initial visual field defects that spared the central field. All 37 patients immediately received high-dose corticosteroid
therapy. Visual acuity worsened by > 2 lines in one of nine patients (11%) with preserved visual acuity,
with a corresponding progression of visual field constriction.
Conclusion—Although preserved visual acuity of 20/40 or better has traditionally been associated with
the nonarteritic form of anterior ischemic optic neuropathy, giant cell arteritis should still be strongly considered, especially if they have giant cell arteritis systemic symptoms.

https://doi.org/10.5281/zenodo.10371776
PDF
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2023 Journal of Vascular and Interventional Neurology

Downloads

Download data is not yet available.